This comprehensive investigation delineates the molecular landscape of pyroptosis-related mechanisms in HCC pathogenesis, particularly highlighting ATP6AP1-mediated tumor microenvironment remodeling as a novel therapeutic target. This evidence concerns the gene ATP6AP1 and hepatocellular carcinoma.